Lv4
566 积分 2023-02-08 加入
Mitochondrial reprogramming in lung cancer: a therapeutic vulnerability and a strategy for reversing drug resistance
1个月前
已完结
Mutant p53 activates hnRNPA2B1-AGAP1-mediated exosome formation to promote esophageal squamous cell carcinoma progression
2个月前
已完结
PET-CT radiomics for immunotherapy response
2个月前
已完结
Diagnostic performance of 18F-FDG PET/CT metabolic parameters for early prediction of pathological response in NSCLC treated with neoadjuvant immuno(chemo)therapy: A systematic review and meta-analysis
2个月前
已完结
Single-cell RNA-sequencing data reveals the genetic source of extracellular vesicles in esophageal squamous cell carcinoma
3个月前
已完结
Mechanisms of function and clinical potential of exosomes in esophageal squamous cell carcinoma
3个月前
已完结
Metabolic reprogramming of tumor-associated macrophages via adenosine-A2AR signaling drives cross-resistance in non-small cell lung cancer
6个月前
已完结
Metabolic Reprogramming in Human Cancer Patients and Patient-Derived Models
7个月前
已完结
Metabolic reprogramming of tumor-associated macrophages via adenosine-A2AR signaling drives cross-resistance in non-small cell lung cancer
7个月前
已完结
Therapeutic targeting of glutamate dehydrogenase 1 that links metabolic reprogramming and Snail-mediated epithelial–mesenchymal transition in drug-resistant lung cancer
7个月前
已完结
皖公网安备34019202002308
